Results 191 to 200 of about 11,965 (231)
Some of the next articles are maybe not open access.
MYOCARDIAL BIOPROSTHESIS: MIMICKING NATURE
Drugs of the Future, 2013Cardiac diseases of ischemic origin are threatening clinical conditions characterized by enlarged dysfunctional hearts and the risk of sudden death, with myocardial infarction being the most common disease. The only definitive treatment at present is a cardiac transplant, but new therapeutic approaches, such as the implantation of isolated cells with ...
Soler-Botija, C +4 more
openaire +3 more sources
Repeat replacement of aortic valve bioprosthesis
The Annals of Thoracic Surgery, 1995We describe a safe and simple technique for replacing an aortic valve bioprosthesis in a patient who also had a previously implanted ascending aortic graft and multiple coronary artery bypass grafts. This method allows for isolated valve replacement without removal of the ascending aortic graft or alteration of the coronary artery bypass graft ...
H J, Safi, D C, Iliopoulos, D S, Duff
openaire +2 more sources
The New Labcor-Santiago Pericardial Bioprosthesis
Journal of Cardiac Surgery, 1991The Labcor-Santiago pericardial valve has been designed to minimize mechanical stress and to avoid abrasion wear, at the same time preserving the concept of mounting the pericardium outside the posts for full orifice opening. The new design has preserved the traditional superior hemodynamic performance of pericardial valves, avoiding abrasion by ...
J B, Garcia-Bengochea +6 more
openaire +2 more sources
The INTACT Bioprosthesis - Early Results
Journal of Cardiac Surgery, 1988The INTACT (previously Xenotech) valve incorporates three major departures from previously available bioprostheses. The following innovations are aimed at reducing calcification and improving durability: (1) the stent has a high profile configuration and the sinuses are deeply excavated.
openaire +2 more sources
Aspergillus cyst of aortic valve bioprosthesis
Journal of Echocardiography, 2011Aspergillus endocarditis (AE) is an ominous complication of cardiac surgery with a dismal prognosis. We present a 35-year-old female who developed AE 4 months after her aortic and mitral valve replacement. Transesophageal echocardiography revealed an aortic root abscess and a cystic mass attached to the aortic bioprosthesis.
Ashraf M, Anwar +5 more
openaire +2 more sources
Aortic valve replacement with stentless bioprosthesis
Khirurgiya. Zhurnal im. N.I. Pirogova, 2016To evaluate prospectively the hemodynamic performance of «BioLAB Mono» stentless bioprosthesis implanted into aortic position.Twenty seven patients (mean age 71 (67; 73); 17 women) with severe aortic stenosis underwent aortic valve replacement with «BioLAB Mono» stentless bioprosthesis from 2012 to 2014.
D A, Astapov +2 more
openaire +2 more sources
Developments in transcatheter aortic bioprosthesis durability
Expert Review of Cardiovascular Therapy, 2019Introduction: Valve durability represents a main concern, as the target population for transcatheter aortic valve implantation (TAVI) evolves to include lower risk and younger patients who are likely to survive for a number of years after the procedure.Areas covered: The purpose of this review article is to provide an overview of potential mechanisms ...
Anna Sonia, Petronio, Cristina, Giannini
openaire +2 more sources
Tissuemed porcine bioprosthesis
The Annals of Thoracic Surgery, 2003Juan Sierra +4 more
openaire +1 more source
Bioprosthesis Versus Mechanical Devices
1988Choice of a valve device in patients requiring cardiac valve replacement is a major consideration addressed by cardiovascular surgeons and cardiologists in the management of patients with valvular heart disease. The large choice of valve substitutes can be classified into 2 major categories (Table 1).
openaire +1 more source